THE INSTITUTE FOR CANCER VACCINES AND IMMUNOTHERAPY

Registered charity 1080343 · accounts filings on the Charity Commission register · also known as CVI, THE CANCER VACCINE INSTITUTE LIMITED

The principal activity of the charity is the advancement of education and the protection and preservation of public health by promoting research into the treatment of cancer by vaccine technology and by promoting the dissemination of the useful results of such research.

Causes: Education/training · The Advancement Of Health Or Saving Of Lives · Grant history (this charity is a funder) · website · Get email alerts

Latest income

£433k

Latest spending

£547k

Registered

2000

Accounts read

FY2025

Financial health, per its FY2025 accounts

The accounts state that the charity reported a net deficit of £122,083 for the year ended 31 March 2025, resulting in a decrease in total net assets to £993,795. Per the trustees' report, unrestricted reserves stood at £852,749, which the trustees consider sufficient to cover committed operating costs and provide flexibility for temporary shortfalls in fundraising revenues. The charity maintains its reserves in cash or cash equivalents to maintain short-term capital value amid market uncertainties.

Automated summary of the FY2025 accounts; the evidenced findings below carry the verbatim passages.

What the accounts disclose

Highest-paid employee band: £70,001 - £80,000 — above the 90th percentile for charities its size (median £60k)

“One employee received remuneration of £70,000 or greater in the band £70,000 - £80,000.” — page 27

Per its FY2025 accounts as filed with the Charity Commission.

Employees paid over £60,000: 1

“One employee received remuneration of £70,000 or greater in the band £70,000 - £80,000.” — page 27

Per its FY2025 accounts as filed with the Charity Commission.

Largest income source: Charitable Trusts/Corporate Donations (42% of income)

“Charitable Trusts/Corporate Donations £157,206”

Per its FY2025 accounts as filed with the Charity Commission.

Fundraising cost ratio: 6.0% of fundraised income, as disclosed

“direct fundraising costs were 6% (2024 6%), with management, support and governance the remaining 18% (2024 15%).”

Per its FY2025 accounts as filed with the Charity Commission.

Reserves policy: three months of unrestricted expenditure (held: £853k)

“The Trustees consider that, given the nature of the committed operating costs) at any one time. The Trustees are of the opinion that this level will provide sufficient flexibility to cover any temporary shortfalls in fundraising revenues or other income flows, will provide adequate working capital to cover core costs and will allow the charity to respond to unforeseen emergencies.”

Per its FY2025 accounts as filed with the Charity Commission.

Accounts audited by Bryden Johnson Limited. Discloses 6 of 6 completeness components.

Public fundraising profile: JustGiving — The Institute for Cancer Vaccines and Immunotherapy (matched by registered charity number).

Structured financials (annual return, FY ending 31/03/2023)

Total income

£621k

Total spending

£585k

Cost of raising funds

£81k

Reserves (reported)

£1.4m

Employees

2

Reported reserves equal ~29.4 months of spending — in the top quarter for charities its size (median 7.0 months; benchmarks).

Per its annual return, largest income source: Donations and legacies (97% of income) — components as reported reconcile to the return’s total income; not from the accounts narrative.

Per its annual return, cost of raising funds: 13.1% of total income — in the top quarter for charities its size (median 2.9%) (benchmarks).

Register events

Received assets from another charity (14/11/2025) — per the register’s event history; asset transfers typically record mergers or reorganisations.

Trustees · trustee networks

Sir HENRY RICHARD GEERS COTTERELL Bt OBEchair
ALEXANDER CHARLES JOHNS
GUY EDMUND SANGSTER
JEMMA KATE NATASHA FREEMAN · trustee of 1 other charity
RESHMA ASHRAF TAYLOR
Saffron Emily Rankin Guy

Trustee list from the Charity Commission register (current, not historical).

Operates in: Throughout England And Wales

Income and spending

Financial year end	Income	Spending
31/03/2025	£433k	£547k
31/03/2024	£261k	£578k
31/03/2023	£621k	£585k
31/03/2022	£566k	£744k
31/03/2021	£685k	£794k

Common questions

Is THE INSTITUTE FOR CANCER VACCINES AND IMMUNOTHERAPY financially healthy?

Per its FY2025 accounts: The accounts state that the charity reported a net deficit of £122,083 for the year ended 31 March 2025, resulting in a decrease in total net assets to £993,795. Per the trustees' report, unrestricted reserves stood at £852,749, which the trustees consider sufficient to cover committed operating costs and provide flexibility for temporary shortfalls in fundraising revenues. The charity maintains its reserves in cash or cash equivalents to maintain short-term capital value amid market uncertainties. Its FY2025 accounts were audited by Bryden Johnson Limited.

What does the highest-paid employee of THE INSTITUTE FOR CANCER VACCINES AND IMMUNOTHERAPY earn?

Per its FY2025 accounts, the highest-paid employee was in the £70,001 - £80,000 band, and 1 employees earned over £60,000.

Who funds THE INSTITUTE FOR CANCER VACCINES AND IMMUNOTHERAPY?

Funders whose own accounts filings name THE INSTITUTE FOR CANCER VACCINES AND IMMUNOTHERAPY as a grant recipient include THE MASTER CHARITABLE TRUST, THE BILLMEIR CHARITABLE TRUST, THE ADRIAN SWIRE CHARITABLE TRUST, THE BELLASIS TRUST, ST ALDHELM'S CHAPEL TRUST.

Known funders

Grants to this charity found in funders’ own accounts filings.

Funder	Year	Amount	Purpose (as stated by the funder)
THE MASTER CHARITABLE TRUST	FY2023	£450k
THE MASTER CHARITABLE TRUST	FY2022	£400k
THE BILLMEIR CHARITABLE TRUST	FY2025	£25k
THE BILLMEIR CHARITABLE TRUST	FY2022	£15k
THE ADRIAN SWIRE CHARITABLE TRUST	FY2024	£15k
THE BELLASIS TRUST	FY2025	£10k
THE BELLASIS TRUST	FY2024	£10k
THE BILLMEIR CHARITABLE TRUST	FY2024	£8k
ST ALDHELM'S CHAPEL TRUST	FY2023	£5k	The relief of physical and mental illness
THE BILLMEIR CHARITABLE TRUST	FY2023	£2k	Donations
SIR SAMUEL SCOTT OF YEWS TRUST	FY2024	£2k
THE MANOUKIAN CHARITABLE FOUNDATION	FY2023	£1k
THE MANOUKIAN CHARITABLE FOUNDATION	FY2022	£1k
THE MANOUKIAN CHARITABLE FOUNDATION	FY2024	£0

Funders of similar charities

Funders whose accounts show grants to charities similar to this one (and no recorded grant to this charity) — a starting list for fundraisers.

Funder	Similar charities funded	Amount to them
NORTH WEST CANCER RESEARCH (INCORPORATING CLATTERBRIDGE CANCER RESEARCH CCR)	1	£101k
TONY RAMPTON TRUST	1	£71k
DAVID LISTER CHARITABLE TRUST	1	£51k
THE A M FENTON TRUST	1	£19k
GREENFIELD BAPTIST CHURCH	1	£3k
THE JENOUR FOUNDATION	1	£3k
THE EARL FITZWILLIAM CHARITABLE TRUST	1	£3k
MILLS AND REEVE CHARITABLE TRUST	1	£1k

Charities like this

Semantically similar by activities and financial character, from our analysed corpus. Compare with INTERNATIONAL CANCER IMAGING SOCIETY.

INTERNATIONAL CANCER IMAGING SOCIETY income £186k
CANCER RESEARCH WALES income £5.9m
NATIONAL CANCER RESEARCH INSTITUTE income £1.6m
THE CANCER TREATMENT AND RESEARCH TRUST CIO income £502k
CANCER AWARENESS TRUST income £1.1m
BRITISH SOCIETY FOR IMMUNOLOGY income £1.8m

Side by side with its peers

Charity	Income	Top pay band	Staff >£60k	Reserves vs policy	Fundraising cost	Going concern
THE INSTITUTE FOR CANCER VACCINES AND IMMUNOTHERAPY	£433k	£70,001 - £80,000	1	unclear	6.0%	no doubt
INTERNATIONAL CANCER IMAGING SOCIETY FY2025	£186k	—	0	unclear	—	no doubt
CANCER RESEARCH WALES FY2026	£5.9m	—	—	unclear	—	no doubt
NATIONAL CANCER RESEARCH INSTITUTE FY2022	£1.6m	—	—	above	—	no doubt
THE CANCER TREATMENT AND RESEARCH TRUST CIO FY2024	£502k	—	0	above	—	no doubt
CANCER AWARENESS TRUST FY2024	£1.1m	£100,001 - £110,000	—	unclear	—	no doubt

Each row is that charity’s latest analysed filing; every value is quote-backed on its own page.